170 related articles for article (PubMed ID: 30640939)
1. TULP3: A potential biomarker in colorectal cancer?
Sartor ITS; Recamonde-Mendoza M; Ashton-Prolla P
PLoS One; 2019; 14(1):e0210762. PubMed ID: 30640939
[TBL] [Abstract][Full Text] [Related]
2. Correlation of clinical features and genetic profiles of stromal interaction molecule 1 (STIM1) in colorectal cancers.
Wong HS; Chang WC
Oncotarget; 2015 Dec; 6(39):42169-82. PubMed ID: 26543234
[TBL] [Abstract][Full Text] [Related]
3. High KCNQ1OT1 expression might independently predict shorter survival of colon adenocarcinoma.
Zhang K; Yan J; Yi B; Rui Y; Hu H
Future Oncol; 2019 Apr; 15(10):1085-1095. PubMed ID: 30932685
[TBL] [Abstract][Full Text] [Related]
4. Molecular profile reveals immune-associated markers of lymphatic invasion in human colon adenocarcinoma.
Shi J; Jiang D; Yang S; Sun Y; Wang J; Zhang X; Liu Y; Lu Y; Yang K
Int Immunopharmacol; 2020 Jun; 83():106402. PubMed ID: 32200154
[TBL] [Abstract][Full Text] [Related]
5. Computational analyses reveal a prognostic impact of TULP3 as a transcriptional master regulator in pancreatic ductal adenocarcinoma.
Sartor IT; Zeidán-Chuliá F; Albanus RD; Dalmolin RJ; Moreira JC
Mol Biosyst; 2014 Jun; 10(6):1461-8. PubMed ID: 24668219
[TBL] [Abstract][Full Text] [Related]
6. Proteomics analysis of differential protein expression identifies heat shock protein 47 as a predictive marker for lymph node metastasis in patients with colorectal cancer.
Mori K; Toiyama Y; Otake K; Fujikawa H; Saigusa S; Hiro J; Kobayashi M; Ohi M; Tanaka K; Inoue Y; Kobayashi Y; Kobayashi I; Mohri Y; Goel A; Kusunoki M
Int J Cancer; 2017 Mar; 140(6):1425-1435. PubMed ID: 27925182
[TBL] [Abstract][Full Text] [Related]
7. Absence of MMP2 expression correlates with poor clinical outcomes in rectal cancer, and is distinct from MMP1-related outcomes in colon cancer.
Wong JC; Chan SK; Schaeffer DF; Sagaert X; Lim HJ; Kennecke H; Owen DA; Suh KW; Kim YB; Tai IT
Clin Cancer Res; 2011 Jun; 17(12):4167-76. PubMed ID: 21531813
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.
Okugawa Y; Toiyama Y; Toden S; Mitoma H; Nagasaka T; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
Gut; 2017 Jan; 66(1):107-117. PubMed ID: 26475630
[TBL] [Abstract][Full Text] [Related]
9. Solute carrier organic anion transporter family member 4A1 (SLCO4A1) as a prognosis marker of colorectal cancer.
Ban MJ; Ji SH; Lee CK; Bae SB; Kim HJ; Ahn TS; Lee MS; Baek MJ; Jeong D
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1437-1447. PubMed ID: 28378090
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of formin-like 3 contributes to metastasis and poor prognosis in colorectal carcinoma.
Zeng YF; Xiao YS; Lu MZ; Luo XJ; Hu GZ; Deng KY; Wu XM; Xin HB
Exp Mol Pathol; 2015 Apr; 98(2):260-7. PubMed ID: 25758200
[TBL] [Abstract][Full Text] [Related]
11. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
[TBL] [Abstract][Full Text] [Related]
12. [Colorectal cancer].
Pox CP; Schmiegel W
Dtsch Med Wochenschr; 2014 Jan; 139(5):193-202; quiz 203-6. PubMed ID: 24449354
[No Abstract] [Full Text] [Related]
13. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
[TBL] [Abstract][Full Text] [Related]
14. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC.
Scarpa M; Scarpa M; Castagliuolo I; Erroi F; Kotsafti A; Basato S; Brun P; D'Incà R; Rugge M; Angriman I; Castoro C
Oncotarget; 2016 Mar; 7(9):10322-31. PubMed ID: 26862732
[TBL] [Abstract][Full Text] [Related]
15. Identification of SATB1 as a Specific Biomarker for Lymph Node Metastasis in Colorectal Cancer.
Baba H; Ishikawa T; Mogushi K; Ishiguro M; Uetake H; Tanaka H; Sugihara K
Anticancer Res; 2016 Aug; 36(8):4069-76. PubMed ID: 27466515
[TBL] [Abstract][Full Text] [Related]
16. High expression of AT-rich interactive domain 3A (ARID3A) is associated with good prognosis in colorectal carcinoma.
Song M; Kim H; Kim WK; Hong SP; Lee C; Kim H
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S481-9. PubMed ID: 24366420
[TBL] [Abstract][Full Text] [Related]
17. Over-Expression of Cyclooxygenase-2 in Colorectal Cancer Patients.
Negi RR; Rana SV; Gupta V; Gupta R; Chadha VD; Prasad KK; Dhawan DK
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1675-1681. PubMed ID: 31244287
[TBL] [Abstract][Full Text] [Related]
18. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
Zou G; Wang R; Wang M
Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
[TBL] [Abstract][Full Text] [Related]
19. Evi-1 Influence on Clinical Progress of Colorectal Cancer Patients.
Zhu Y; Zhang J; Ye Z; Peng P; Lan X; Xie L; Qin M; Huang J
Ann Clin Lab Sci; 2020 May; 50(3):354-360. PubMed ID: 32581025
[TBL] [Abstract][Full Text] [Related]
20. Clinical Significance of miR-1826 as a Novel Prognostic Biomarker in Colorectal Cancer.
Hu Y; Yi B; He S; Gao L; Liu P; Wang L; Yu J; Wan D; Zhou J; Zhu X; Zhi Q
Anticancer Agents Med Chem; 2016; 16(9):1109-16. PubMed ID: 25968874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
